Headlines

Journalists Assess Health Impacts of Trump’s Megabill, Who Will Feel Them, and When
21 hours ago
Friday Links
2 days ago
From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology
2 days ago
With FDA Nod in Lung Cancer, Dizal Now Aims to Best a J&J Drug and Succeed Where Takeda Fell Short
2 days ago
Eko Health’s AI for Cardiac Diagnoses Earns CMS Reimbursement Rate
2 days ago
States Brace for Reversal of Obamacare Coverage Gains Under Trump’s Budget Bill
2 days ago

Medicine

Why Novo Nordisk Is Dropping Its Collaboration with Hims & Hers

2 weeks ago01 mins

Novo Nordisk is ending its partnership with Hims & Hers due to concerns over its practices related to compounded GLP-1s.

The post Why Novo Nordisk Is Dropping Its Collaboration with Hims & Hers appeared first on MedCity News.

Leave a Reply Cancel reply

Related News

From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology

2 days ago 0

With FDA Nod in Lung Cancer, Dizal Now Aims to Best a J&J Drug and Succeed Where Takeda Fell Short

2 days ago 0

Eko Health’s AI for Cardiac Diagnoses Earns CMS Reimbursement Rate

2 days ago 0

What Administering My Father’s Home Infusions for 10 Years Taught Me About Improving Chronic Illness Care

3 days ago 0